BMS 250MG 6673 (Videx EC 250 mg)
Generic Name: didanosine
Pill with imprint BMS 250MG 6673 is White, Capsule-shape and has been identified as Videx EC 250 mg. It is supplied by Bristol-Myers Squibb.
Videx EC is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Videx EC 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 250MG 6673
Videx EC
- Generic Name
- didanosine
- Imprint
- BMS 250MG 6673
- Strength
- 250 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (nrtis)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- Inactive Ingredients
-
carboxymethylcellulose sodium,
diethyl phthalate,
methacrylic acid - methyl methacrylate copolymer (1:2),
sodium hydroxide,
sodium starch glycolate type A potato,
magnesium silicate,
gelatin,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00087-6673 (Discontinued) | Bristol-Myers Squibb Company |
| 54569-5504 | A-S Medication Solutions, LLC (repackager) |
| 54868-5595 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about Videx EC (didanosine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.